NASDAQ · UROYFinancialsSecurities & Investments

Uranium Royalty financials

$4.08+2.00%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Apr 30
FY24
Apr 30
FY23
Apr 30
FY22
Apr 30
FY21
Apr 30
Revenue$11.3M$31.0M$10.2M$0.00$0.00
Gross profit$2.6M$10.7M$2.1M$0.00$0.00
Gross margin22.7%34.6%20.3%——
Operating income-$3.5M$5.1M-$2.8M-$4.4M-$1.2M
Net income-$4.1M$7.1M-$4.3M-$3.3M-$1.1M
Net margin−36.3%22.9%−42.2%——
Diluted EPS$-0.03$0.06$-0.06$-0.05$-0.02
EBITDA-$3.4M$5.2M-$2.8M-$4.4M-$1.2M
Operating cash flow-$15.7M-$76.1M-$8.5M-$53.6M-$11.2M
Free cash flow-$15.7M-$76.1M-$8.5M-$53.6M-$11.2M
Diluted shares126.8M115.3M97.9M88.3M72.0M

Balance sheet

Period endApr 30Apr 30Apr 30Apr 30Apr 30
Cash & equivalents$9.4M$15.3M$10.6M$3.4M$5.9M
Short-term investments$5.2M$6.6M$28.3M$40.3M$24.4M
Total debt$0.00$0.00$7.2M$80.2K$0.00
Total assets$214.7M$202.3M$137.0M$138.7M$62.0M
Total liabilities$853.5K$2.1M$7.7M$10.5M$445.1K
Shareholders' equity$213.8M$200.2M$129.3M$128.2M$61.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology